European Companies Search Engine
EU funding (€4,955,877): Towards enduring mouse resources and services advancing research into human health and disease Hor19 Dec 2016 EU Research and Innovation programme "Horizon"
Overview
Text
Towards enduring mouse resources and services advancing research into human health and disease
The INFRAFRONTIER RI integrates European Mouse Clinics and the European Mouse Mutant Archive with the common goal to ensure access to mouse models for basic research of human health and disease, and to translate this knowledge into therapeutic approaches for the benefit of the European society. The expanded INFRAFRONTIER2020 network, coordinated by the INFRAFRONTIER GmbH, includes 3 SMEs and is strategically responding to the INFRADEV3 call with aligned objectives to advance the long-term sustainability which are 1) development of business models and a stable legal framework; 2) raise awareness of the INFRAFRONTIER RI; 3) provide bespoke services aligned with user demands; 4) promote best practices in mouse phenogenomics; 5) enhance robustness of the INFRAFRONTIER IT infrastructure and use of the EMMA strain resource; and 6) improve business processes. Towards achieving these objectives key INFRAFRONTIER2020 project deliverables are: • INFRAFRONTIER Business Plan2.0, and business models for all services • Stable legal framework built on the INFRAFRONTIER legal entity • INFRAFRONTIER annual stakeholder conferences • Customised mouse model and secondary phenotyping pilot services • INFRAFRONTIER advanced training schools in mouse phenogenomics • Reengineered EMMA Database2.0 system • Annotated mouse models of human diseases • Quality management system for the legal entity INFRAFRONTIER2020 will 1) enhance the sustainable operation of the INFRAFRONTIER RI; 2) continue to structure the ERA, 3) foster innovation, and 4) address major societal challenges in human health by customised service pilots supporting research into common and rare diseases. A sustainable INFRAFRONTIER RI will ensure the quality of deposited mice and support the reproducibility of biological results. Outreach efforts will raise awareness of resources and services and facilitate sustainable engagement with industry and global consortia such as the International Mouse Phenotyping Consortium
Funded Companies:
| Company name | Funding amount |
| AYOXXA BIOSYSTEMS GmbH | €20,800 |
| Academisch Ziekenhuis Groningen | €20,800 |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | €72,625 |
| €91,125 | |
| Centre Europeen de Recherche en Biologie et Medecine | €306,900 |
| Centre National de la Recherche Scientifique Cnrs | €69,774 |
| Consiglio Nazionale Delle Ricerche | €384,000 |
| €212,800 | |
| €215,600 | |
| FUNDACAO CALOUSTE GULBENKIAN | €120,540 |
| Genome Research Ltd. | €69,875 |
| HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM für GESUNDHEIT UND UMWELT GmbH | €477,873 |
| HELMHOLTZ-ZENTRUM für INFEKTIONSFORSCHUNG GmbH | €12,800.00 |
| INFRAFRONTIER GmbH | €1,713,235 |
| Institut National de la Sante et de la Recherche Medicale | €220,925 |
| Institut Pasteur | €42,600 |
| Karolinska Institutet | €77,321 |
| Kobenhavns Universitet | €22,400 |
| MEDIZINISCHE HOCHSCHULE HANNOVER | €17,600.00 |
| OULUN YLIOPISTO | €140,100 |
| Stichting HET Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis | €114,750 |
| €12,800.00 | |
| TSE SYSTEMS GmbH | €25,600 |
| €40,800 | |
| €0.00 | |
| United Kingdom Research and Innovation | €227,906 |
| Universitat Autonoma de Barcelona | €12,800.00 |
| €195,528 | |
| Veterinaermedizinische Universitaet Wien | €16,000.00 |
Source: https://cordis.europa.eu/project/id/730879
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "AYOXXA BIOSYSTEMS GmbH - EU funding (€4,955,877): Towards enduring mouse resources and services advancing research into human health and disease"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
